Group Lead- Downstream Process Development , AAV Chromatography

Bedford, MA
Sep 03, 2019
Required Education
Masters Degree/MBA
Position Type
Full time

Group Lead- Downstream Process Development , AAV Chromatography

Job Code: SDPD010-18

Location: Bedford, MA


The successful candidate will be an integral part of a fast paced and rapidly growing group of scientists and engineers developing purification processes for the manufacture of our proprietary adeno-associated virus (AAV) based gene therapy and gene editing products. Responsibilities will include helping to develop and oversee the development of multiple unit operations with an emphasis on chromatographic separations. Critical to this role is the ability to lead the end to end development of a purification process and to be able to effectively communicate results through high quality technical reports and oral presentations.


Primary responsibilities:

  • Lead and manage groups in the development of GMP ready purification processes
  • Plan and execute studies related to the recovery and purification of AAV from cell harvest through final formulation.
  • Plan and execute of pilot scale production to support process development and research activities
  • Lead the tech transfer of GMP processes to internal and external manufacturing organizations
  • Be a chromatographic separations leader within the organization
  • Present of development studies results and process development progress.
  • Lead the authoring of technical reports and CMC sections for regulatory filings.


  • A strong background in the fundamentals and scale-up of chromatographic based separations with biologic molecules.
  • Experience with development of purification processes for AAV and/or other viral vectors or vaccines is highly preferred.
  • Experience with managing groups and overseeing GMP process development is required
  • Demonstrated ability to work effectively in a cross-functional team.
  • Strong verbal and written communication skills.

Education & Experience

BS (9+ years), MS (6+) or PhD (3+) years of directly related experience. Degree emphasis in Chemical Engineering, Biochemistry, Bioengineering, or related discipline preferred.

Homology Medicines, Inc. (HMI) has built foundational intellectual property on gene editing and gene therapy vectors derived from naturally occurring human adeno-associated viruses (AAVs). The Company's technology is precise, on-target and highly efficient for in vivo editing of genetic mutations. This transformative platform technology, combined with an elite leadership team of biopharmaceutical industry veterans, create a significant opportunity for HMI to rapidly advance a diverse pipeline of new medicines that address and potentially cure the underlying cause of genetic diseases.